Bibliograph

Drug safety, preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Type

Label

Drug safety, preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Language

eng

Bibliography note

Includes bibliographical references

resource.governmentPublication

federal national government publication

Index

no index present

Literary Form

non fiction

Main title

Drug safety

Medium

electronic resource

Nature of contents

dictionariesbibliography

Oclc number

232330615

Responsibility statement

statement of Marcia Crosse

Series statement

Testimony, GAO-08-701 T

Sub title

preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

resource.variantTitle

Drug safety, preliminary findings suggest recent Food and Drug Administration initiatives have potential, but do not fully address weaknesses in its foreign drug inspection programPreliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program

Contributor

Creator